PAR PHARMACEUTICAL COMPANIES, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$139.5M

805 transactions

Summary

PAR PHARMACEUTICAL COMPANIES, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $7.3MSales: $45.9M35 insiders

Date	Insider	Type	Value
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$2.3M
2012-09-28	HAUGHEY THOMAS(President)	D	$1.7M
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$1.3M
2012-09-28	HAUGHEY THOMAS(President)	D	$1.3M
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$1.3M
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$1.3M
2012-09-28	HAUGHEY THOMAS(President)	D	$1.3M
2012-09-28	HAUGHEY THOMAS(President)	D	$1.3M
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$841K
2012-09-28	HAUGHEY THOMAS(President)	D	$340K
2012-09-28	HAUGHEY THOMAS(President)	D	$123K
2012-09-28	HAUGHEY THOMAS(President)	D	$118K
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$82K
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$74K
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	$71K
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	—
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	—
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	—
2012-09-28	Campanelli Paul(Chief Executive Officer)	D	—
2012-09-28	HAUGHEY THOMAS(President)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

PAR PHARMACEUTICAL COMPANIES, INC. — Contributions, Lobbying & Contracts | Poliscope